Today: 28 April 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Telix stock price slides 8% as investors digest FY25 revenue update and China Illuccix filing

Telix stock price slides 8% as investors digest FY25 revenue update and China Illuccix filing

Telix Pharmaceuticals shares fell 7.7% to A$10.61 at Wednesday’s close after the company reported unaudited FY2025 revenue in line with guidance and noted early momentum for Gozellix. China’s drug regulator accepted the Illuccix application, triggering a formal review. Investors weighed ongoing U.S. regulatory developments and recent clinical trial results.
21 January 2026
··
Adani Power wins key tribunal nod for Rs 4,000 crore Vidarbha plant takeover

Adani Power wins key tribunal nod for Rs 4,000 crore Vidarbha plant takeover

India’s insolvency appellate tribunal approved Adani Power’s Rs 4,000 crore resolution plan for Vidarbha Industries Power, dismissing appeals from Western Coalfields and an employee representative. The tribunal upheld the payout structure but ordered full payment of provident fund and gratuity dues. The decision removes a key obstacle to Adani’s acquisition of the 600 MW Maharashtra plant. Court documents show creditor approval was secured in February 2025.
21 January 2026
·
BHP share price rebounds after China iron ore talks, potash cost jump rattles investors

BHP share price rebounds after China iron ore talks, potash cost jump rattles investors

BHP shares closed up 1.47% at A$48.48, rebounding after Tuesday’s drop. The company warned of price concessions in ongoing iron ore supply talks with China and raised its Jansen potash project cost estimate to $8.4 billion. Copper prices rose 32% year-on-year, and iron ore edged up 4%. Investors await BHP’s half-year results on Feb. 17.
21 January 2026
···
CSL share price slips after close as RBC upgrade turns focus to Feb. 11 results

CSL share price slips after close as RBC upgrade turns focus to Feb. 11 results

CSL shares closed down 0.33% at A$176.11 on Wednesday, staying well below last year’s highs. RBC Capital upgraded CSL to “Outperform” and raised its price target to A$230, citing valuation upside despite weak U.S. flu vaccine demand. Investors are focused on CSL’s half-year results and interim dividend due Feb. 11. The S&P/ASX 200 slipped 0.37% amid broader market volatility.
21 January 2026
··
Fortescue share price rises as FMG investors eye quarterly report and iron ore jitters

Fortescue share price rises as FMG investors eye quarterly report and iron ore jitters

Fortescue shares rose 1.7% to A$22.64, rebounding ahead of its December production report due Thursday. The ASX 200 slipped 0.4%, but materials gained 2.7% on miner strength. Iron ore futures fell after weak China property data, while a fatal blast at a Chinese steel plant raised supply concerns. BHP agreed to lower some iron ore prices in ongoing talks with China Mineral Resources Group.
21 January 2026
···
Why UMC stock is up 16% today: 8-inch price hike talk meets Taiwan’s CPO buzz

Why UMC stock is up 16% today: 8-inch price hike talk meets Taiwan’s CPO buzz

United Microelectronics Corp shares jumped 16% Tuesday, closing at $10.82 and leading semiconductor gains as U.S. markets fell. Taipei-listed UMC hit the daily limit before settling up 6-7%, fueled by rumors of 8-inch wafer price hikes. Foreign investors remained net buyers, and UMC confirmed its Singapore Fab 12i P3 expansion is moving toward mass production by 2027. Investors await UMC’s earnings report on Jan. 28.
20 January 2026
··
HYMC stock jumps nearly 17% as silver breaks $95 — what’s driving Hycroft Mining today

HYMC stock jumps nearly 17% as silver breaks $95 — what’s driving Hycroft Mining today

Hycroft Mining shares jumped 16.8% to $40.45 Tuesday as gold hit $4,700 an ounce and silver reached $95, both record highs. Canadian investor Eric Sprott exercised over 4.6 million warrants and bought 200,000 shares last week. Hycroft, which owns a large Nevada mine, has no current production and warned it needs more funding to advance development. Trading volume neared 3 million shares by midday.
20 January 2026
···
Qiagen stock price jumps nearly 16% as Bloomberg report revives sale talk

Qiagen stock price jumps nearly 16% as Bloomberg report revives sale talk

Qiagen shares jumped 15.9% to $55.13 in U.S. trading Tuesday after reports the diagnostics firm is exploring strategic options, including a potential sale, and has hired advisers. Bloomberg said the company’s board is handling new takeover interest, but talks remain preliminary. Qiagen will report fourth-quarter results Feb. 4, with a conference call set for Feb. 5. The company has not commented on the reports.
20 January 2026
··
MARA stock slides as CEO Thiel trust flags share sale while bitcoin dips

MARA stock slides as CEO Thiel trust flags share sale while bitcoin dips

MARA shares fell 5.1% to $10.78 by midday Tuesday after a filing showed CEO Fred Thiel’s trust intends to sell 27,505 shares under Rule 144. Bitcoin dropped 3%, pressuring mining stocks. The planned sale, valued at $297,054, follows similar trust sales in November and December. Traders are watching for a follow-up insider filing and bitcoin’s next move.
20 January 2026
···
AstraZeneca stock price slides as AZN sets Nasdaq exit, NYSE move dates

AstraZeneca stock price slides as AZN sets Nasdaq exit, NYSE move dates

AstraZeneca shares fell 4.4% to $90.23 Tuesday after the company said it will delist its American depositary shares from Nasdaq and move to a direct listing of ordinary shares on the NYSE starting February 2. The switch, set for after markets close January 30, comes as European stocks face pressure from U.S. tariff threats. AstraZeneca’s London shares also dropped 2.6%.
20 January 2026
···
1 … 184 185 186 187 188 … 584

Stock Market Today

  • Meta shares face uncertain earnings outlook with volatile options trading
    April 28, 2026, 1:02 PM EDT. Meta Platforms is set to report earnings Wednesday, with analysts noting strong fundamentals including 30% year-on-year revenue growth driven by improved ad pricing and targeting. However, technical indicators raise caution as the stock hovers near its 150-day moving average, suggesting a fragile technical position. The options market is pricing in a sizable 7.5% move post-earnings, reflecting recent large price swings. Recent activity shows heavy call option buying, but traders are advised to consider call spread risk reversals to balance risk and reward. Historical data reveals buying Meta stock into earnings carries a modest average return but with high volatility, making defined-risk options strategies appealing to limit downside while maintaining upside potential.

Latest article

Dow Jones Today: Why The Dow Is Holding Up While Nasdaq Sinks On AI Worries

Dow Jones Today: Why The Dow Is Holding Up While Nasdaq Sinks On AI Worries

28 April 2026
The Dow rose 100.62 points to 49,268.41 on Tuesday, lifted by gains in Coca-Cola and Johnson & Johnson, while the S&P 500 fell 0.64% and the Nasdaq dropped 1.24% as investors sold AI-linked shares. Coca-Cola reported Q1 net revenue up 12% and raised its full-year earnings forecast. Nvidia, AMD, and Arm all declined sharply. Brent crude hovered near $111 amid U.S.-Iran tensions and OPEC uncertainty.
Why Zimmer Biomet Stock Sank After a Q1 Earnings Beat and Raised Profit Outlook

Why Zimmer Biomet Stock Sank After a Q1 Earnings Beat and Raised Profit Outlook

28 April 2026
Zimmer Biomet shares dropped about 9% Tuesday despite beating first-quarter estimates and raising its 2026 profit forecast, as investors reacted to an unchanged sales outlook and the exit of CFO Suketu Upadhyay. The stock traded at $84.17 late morning. The company reported $2.087 billion in net sales and raised its adjusted EPS forecast to $8.40–$8.55. CEO Ivan Tornos cited disruption from a U.S. sales-force overhaul.
Go toTop